Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine Extermann

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Journal of Geriatric Oncology|October 17, 2016
Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkersMartine Extermann, Christiaan Leeuwenburgh, Laila Samiian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2012
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipientsLori S Muffly, Melissa Boulukos, Kate Swanson, et al.
Journal of Comorbidity|November 2, 2017
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancerMaren A van Waalwijk, Saskia A M van de Schans, Harm R Haak, et al.
Critical Reviews in Oncology/Hematology|August 9, 2005
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)Martine Extermann, Matti Aapro, Roberto Bernabei, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.
Journal of General Internal Medicine|July 1, 2005
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health statusJeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff, et al.
Journal of Geriatric Oncology|September 23, 2023
Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)Martine Extermann, Andrew Artz, Maite Antonio Rebollo, et al.
Cancer|November 11, 2011
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) scoreMartine Extermann, Ivette Boler, Richard R Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Reply to L.K. Mell et alKarla V Ballman, Murielle Mauer, Ulrich Wedding, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Journal of Geriatric Oncology|October 17, 2016
Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkersMartine Extermann, Christiaan Leeuwenburgh, Laila Samiian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2012
Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipientsLori S Muffly, Melissa Boulukos, Kate Swanson, et al.
Journal of Comorbidity|November 2, 2017
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancerMaren A van Waalwijk, Saskia A M van de Schans, Harm R Haak, et al.
Critical Reviews in Oncology/Hematology|August 9, 2005
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)Martine Extermann, Matti Aapro, Roberto Bernabei, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 7, 2020
Defining Acute Myeloid Leukemia Ontogeny in Older PatientsMegan Melody, Andrew Kuykendall, David Sallman, et al.
Journal of General Internal Medicine|July 1, 2005
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health statusJeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff, et al.
Journal of Geriatric Oncology|September 23, 2023
Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG)Martine Extermann, Andrew Artz, Maite Antonio Rebollo, et al.
Cancer|November 11, 2011
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) scoreMartine Extermann, Ivette Boler, Richard R Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2014
Reply to L.K. Mell et alKarla V Ballman, Murielle Mauer, Ulrich Wedding, et al.
Cancer|February 27, 2008
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or olderGeorge R Simon, Martine Extermann, Alberto Chiappori, et al.
Pageof 15